Sionna Therapeutics, Inc.
SION
$6.46
-$0.08-1.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 89.16% | 104.29% | 116.45% | 99.74% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.87% | 28.36% | 26.12% | 28.43% | -- |
| Operating Income | -24.87% | -28.36% | -26.12% | -28.43% | -- |
| Income Before Tax | -28.41% | -29.01% | -22.01% | -22.45% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -28.41% | -29.01% | -22.01% | -22.45% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.41% | -29.01% | -22.01% | -22.45% | -- |
| EBIT | -24.87% | -28.36% | -26.12% | -28.43% | -- |
| EBITDA | -25.04% | -28.63% | -26.40% | -28.72% | -- |
| EPS Basic | 78.43% | 84.47% | 87.53% | 69.86% | -- |
| Normalized Basic EPS | 78.43% | 84.47% | 87.53% | 69.86% | -- |
| EPS Diluted | 78.43% | 84.47% | 87.53% | 69.86% | -- |
| Normalized Diluted EPS | 78.43% | 84.47% | 87.53% | 69.86% | -- |
| Average Basic Shares Outstanding | 124.01% | 357.02% | 935.09% | 769.76% | -- |
| Average Diluted Shares Outstanding | 124.01% | 357.02% | 935.09% | 769.76% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |